IL10 and myeloid sarcoma: A dysregulation of IL-10 and LTα has been shown in patients with MS with a higher percentage of B cells producing LTα (18, 19) and a lower percentage of B cells producing IL-10 (17, 19) and these imbalances have been suggested to contribute to exaggerated Th1 and Th17 responses in MS (19).